199 related articles for article (PubMed ID: 17706812)
1. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
Fiotti N; Altamura N; Orlando C; Simi L; Reimers B; Pascotto P; Zingone B; Pascotto A; Serio M; Guarnieri G; Giansante C
Int J Cardiol; 2008 Jul; 127(3):350-7. PubMed ID: 17706812
[TBL] [Abstract][Full Text] [Related]
2. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
3. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K
Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.
Chen F; Eriksson P; Hansson GK; Herzfeld I; Klein M; Hansson LO; Valen G
Int J Mol Med; 2005 Jan; 15(1):57-65. PubMed ID: 15583828
[TBL] [Abstract][Full Text] [Related]
8. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
9. The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas.
Paek SH; Kim DG; Park CK; Phi JH; Kim YY; Im SY; Kim JE; Park SH; Jung HW
Oncol Rep; 2006 Jul; 16(1):49-56. PubMed ID: 16786122
[TBL] [Abstract][Full Text] [Related]
10. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
11. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
12. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
Zhang H; Lin QD; Qiao C
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
[TBL] [Abstract][Full Text] [Related]
13. Role of matrix metalloproteinases in coronary artery disease.
Shah VK; Shalia KK; Mashru MR; Soneji SL; Abraham A; Kudalkar KV; Vasvani JB; Sanghavi ST
Indian Heart J; 2009; 61(1):44-50. PubMed ID: 19729688
[TBL] [Abstract][Full Text] [Related]
14. Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.
Robertson L; Grip L; Mattsson Hultén L; Hulthe J; Wiklund O
J Intern Med; 2007 Dec; 262(6):659-67. PubMed ID: 17927738
[TBL] [Abstract][Full Text] [Related]
15. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
Suminoe A; Matsuzaki A; Hattori H; Koga Y; Ishii E; Hara T
Leuk Res; 2007 Oct; 31(10):1437-40. PubMed ID: 17350093
[TBL] [Abstract][Full Text] [Related]
18. The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
Furenes EB; Arnesen H; Solheim S; Grøgaard HK; Hoffmann P; Seljeflot I
Thromb Res; 2009 Nov; 124(5):560-4. PubMed ID: 19410278
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases-9 and tissue inhibitors of matrix metalloproteinases-1 in connective tissue of vaginal wall of women with stress urinary incontinence].
Zhang QF; Song YF; Zhu ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):810-3. PubMed ID: 17327109
[TBL] [Abstract][Full Text] [Related]
20. [Expression of MMP-2, MMP-9 and TIMP-1 and the effects of methylprednisolone in EAM].
Zhang N; Xiao B; Li J
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):5-8. PubMed ID: 12934382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
